Fig. 2From: Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basisForest plot of hazard ratios for overall survival in groups by tumor types, intervention/control arms, and intervals (months) between SRS and ICI defined as “concurrent”Back to article page